Meeting
2017 ASCO Annual Meeting
TARIBO trial: Cytoreductive nephrectomy in metastatic renal cell carcinoma patients treated with targeted agents.
Authors
Paolo Grassi
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Paolo Grassi , Elena Verzoni , Alessandra Bearz , Sergio Bracarda , Marco Bregni , Sebastiano Buti , Saverio Cinieri , Ugo De Giorgi , Giuseppe Fornarini , Luca Galli , Michele Milella , Franco Morelli , Franco Nole , Rodolfo Passalacqua , Roberto Sabbatini , Daniele Santini , Roberto Salvioni , Vera Cappelletti , Raffaele Ratta , Giuseppe Procopio
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary (Nonprostate) Cancer
Track
Genitourinary Cancer—Kidney and Bladder
Sub Track
Kidney Cancer
Clinical Trial Registration Number
NCT02535351
Citation
J Clin Oncol 35, 2017 (suppl; abstr TPS4601)
DOI
10.1200/JCO.2017.35.15_suppl.TPS4601
Abstract #
TPS4601
Poster Bd #
273b
Abstract Disclosures
Similar Posters
Poster
2016 ASCO Annual Meeting
TARIBO trial: Targeted therapy with or without nephrectomy in metastatic renal cell carcinoma (mRCC)—Liquid biopsy for biomarkers discovery.
First Author: Elena Verzoni
Poster
2021 Genitourinary Cancers Symposium
The impact of hypertension on response rates in patients with renal cell carcinoma.
First Author: Diana Maslov
Poster
2020 Genitourinary Cancers Symposium
Optimal sequence strategy with nivolumab and targeted therapy in patients with metastatic renal cell carcinoma (mRCC).
First Author: Juliette Logeart
Poster
2013 Genitourinary Cancers Symposium
Sequential use of targeted therapies for metastatic renal cell carcinoma: A physician survey and chart review of community oncology practices in the United States.
First Author: Nicholas J. Vogelzang